Skip to content
10-Q

Quarterly Report

RESMED INC RMD RSMDF

0000943819-25-000008

← back to feed
Filed
Apr 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Apr 21, 2025 146.63M sh
Short Term Debt Q3 2025 · Mar 31, 2025 $9.91M
Short Term Debt Q3 2025 · Jun 30, 2024 $9.9M
Cash And Equivalents Q3 2025 · Mar 31, 2025 $932.71M
Cash And Equivalents Q3 2025 · Jun 30, 2024 $238.36M
Current Liabilities Q3 2025 · Mar 31, 2025 $940.52M
Current Liabilities Q3 2025 · Jun 30, 2024 $910.66M
Total Liabilities Q3 2025 · Mar 31, 2025 $2.02B
Total Liabilities Q3 2025 · Jun 30, 2024 $2.01B
Current Assets Q3 2025 · Mar 31, 2025 $3.21B
Current Assets Q3 2025 · Jun 30, 2024 $2.36B
Total Assets Q3 2025 · Mar 31, 2025 $7.57B
Total Assets Q3 2025 · Jun 30, 2024 $6.87B
Shares Diluted Q3 2025 · Mar 31, 2024 147.45M sh
Shares Diluted Q3 2025 · Mar 31, 2024 147.55M sh
Stock Repurchased Q3 2025 · Mar 31, 2024 $100.01M
Dividends Paid Q3 2025 · Mar 31, 2024 $211.77M
Capex Q3 2025 · Mar 31, 2024 $74.58M
Operating Cash Flow Q3 2025 · Mar 31, 2024 $961.15M
Stockholders Equity Q3 2025 · Mar 31, 2024 $4.63B
Stockholders Equity Q3 2025 · Dec 31, 2023 $4.48B
Stockholders Equity Q3 2025 · Sep 30, 2023 $4.25B
Stockholders Equity Q3 2025 · Jun 30, 2023 $4.13B
Eps Diluted Q3 2025 · Mar 31, 2024 $2.04
Eps Diluted Q3 2025 · Mar 31, 2024 $4.94
Eps Basic Q3 2025 · Mar 31, 2024 $2.04
Eps Basic Q3 2025 · Mar 31, 2024 $4.96
Sga Expense Q3 2025 · Mar 31, 2024 $229.92M
Sga Expense Q3 2025 · Mar 31, 2024 $674.95M
Rd Expense Q3 2025 · Mar 31, 2024 $77.07M
Rd Expense Q3 2025 · Mar 31, 2024 $226.66M
Net Income Q3 2025 · Mar 31, 2024 $300.49M
Net Income Q3 2025 · Mar 31, 2024 $728.72M
Net Income Q3 2025 · Dec 31, 2023 $208.8M
Net Income Q3 2025 · Sep 30, 2023 $219.42M
Operating Income Q3 2025 · Mar 31, 2024 $374.58M
Operating Income Q3 2025 · Mar 31, 2024 $938.68M
Gross Profit Q3 2025 · Mar 31, 2024 $692.78M
Gross Profit Q3 2025 · Mar 31, 2024 $1.94B
Cost Of Revenue Q3 2025 · Mar 31, 2024 $504.2M
Cost Of Revenue Q3 2025 · Mar 31, 2024 $1.52B
Revenue Q3 2025 · Mar 31, 2024 $1.2B
Revenue Q3 2025 · Mar 31, 2024 $3.46B